This grant funds early-stage, highly innovative technology development for improving analysis and handling of biospecimens in basic or clinical cancer research, focusing on proof-of-concept studies.
This grant funds projects to further develop and validate innovative technologies that advance cancer research or clinical care, focusing on technical improvements and rigorous validation for broad adoption.
This grant funds further development and validation of new molecular and cellular analysis technologies to improve basic and clinical cancer research, excluding projects using existing technologies for new targets.
The National Cancer Institute will soon invite applications to develop innovative, user-friendly informatics technologies that advance cancer research, spanning early tool development to initial dissemination.
This grant funds the further development and maintenance of advanced informatics tools that support all stages of cancer research, from biology to prevention, under the NCI’s ITCR Program.